Canton Strategic Holdings, Inc. CNTN

Q2 FY2026 · ended Jun 30, 2026 · Revenue $1.50M · Filed Aug 14, 2026

Canton Strategic Holdings, Inc. (CNTN) files with the SEC under industry code 6199, Finance Services. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $1.5 million and a net loss of $19.3 million.

Revenue
$1.50M
Net income
$-19.25M
-937.9% vs year-ago quarter
Operating cash flow
$-2.24M
-95.9% vs year-ago quarter
Free cash flow
—
EPS
$-0.09
+86.1% vs year-ago quarter
Dividend per share
None
Shares outstanding
79.68M
+1619.0% vs year-ago quarter
Net cash
—
Operating margin
-80.4%
Q2 FY2026

Company profile

Industry
Finance Services (SIC 6199)
Listed as
CNTN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
, Emerging growth company
SEC CIK
1861657
Former names
Tharimmune, Inc. (until Feb 11, 2026); Hillstream BioPharma Inc. (until Sep 12, 2023)

Other Finance Services companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$1.5M
—
—
—
—
Operating income
-$1.2M
-$36.9M
-$13.6M
-$2.1M
-$1.4M
Net income
-$19.3M
-$47.3M
-$29.4M
-$2.1M
-$1.9M
Diluted EPS
-$0.09
-$0.23
-$0.26
-$0.34
-$0.64
Operating cash flow
-$2.2M
-$7.6M
-$10.4M
-$1.9M
-$1.1M
Total assets
$564.6M
$584.7M
$519.1M
$7.7M
$2.5M
Total liabilities
$109.7M
$114.9M
$121.2M
$1.5M
$2.2M
Stockholders' equity
$454.9M
$469.8M
$397.9M
$6.2M
$367,359
Cash and investments
$37.2M
—
—
$7.6M
$2.2M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Oct 29, 2026 Oct 29, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Other events
Jul 23, 2026 Jul 17, 2026
8-K Current report
Shareholder vote results, Other events
Jul 17, 2026 Jul 13, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 16, 2026 Jun 11, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.